ARTHROGENIC ALPHAVIRUS VACCINE
- 總結
- Vaccine comprising live attenuated recombinant alphavirus vaccine comprising mutated capsid protein
- 技術優勢
- Vaccine to prevent alphavirus infections such as Chikungunya and Ross River Fever.
- 技術應用
- Vaccine - disease prevention
- 詳細技術說明
- This invention relates to a vaccine comprising live attenuated recombinant alphavirus comprising mutated capsid protein as well as a method for preventing a subject from contracting an alphaviral infection that would otherwise produce clinical signs of disease. In an embodiment that mutated capsid protein is Chikungunya virus capsid protein having mutated nucleolar localisation signal/sequence.
- 合作類型
- Licensing
- 申請日期
- 25/05/2017 00:00:00
- 申請號碼
- PCT/AU2017/050489
- 國家/地區
- 美國
欲了解更多信息，請點擊 這裡
